John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 3,693 shares at $264.87 ($981K) on 2026-06-16, disclosed to the SEC on 2026-06-18.
Open-market sale of $981k ONC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $264.87 | 1,650 | $437K | 44.6% |
| 2 | $265.99 | 1,710 | $455K | 46.4% |
| 3 | $266.69 | 333 | $89K | 9.1% |
| Total | $265.55 avg | 3,693 | $981K | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |